[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Meng, Fan-yi
[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia]. [electronic resource] - Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA Nov 2003 - 1149-50 p. digital
Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
1000-2588
Adolescent
Adult
Antineoplastic Agents--therapeutic use
Benzamides
Female
Follow-Up Studies
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Leukemia, Myeloid, Chronic-Phase--blood
Male
Middle Aged
Piperazines--adverse effects
Pyrimidines--adverse effects
[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia]. [electronic resource] - Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA Nov 2003 - 1149-50 p. digital
Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
1000-2588
Adolescent
Adult
Antineoplastic Agents--therapeutic use
Benzamides
Female
Follow-Up Studies
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Leukemia, Myeloid, Chronic-Phase--blood
Male
Middle Aged
Piperazines--adverse effects
Pyrimidines--adverse effects